Home » Topics » BioWorld Science

BioWorld Science
RSS

Interim data on psilocybin plus NAC in rodent model of mild TBI and PTSD

Sep. 29, 2021

Gamida Cell announces new NK cell construct development programs

Sep. 29, 2021

SBIR grant supports Senti's development of CAR-NK cell therapy SENTI-202 for AML

Sep. 29, 2021

Point Biopharma reports preclinical data on FAP-alpha inhibitor program

Sep. 29, 2021

RARA identified as a druggable target for pediatric acute myeloid leukemia

Sep. 29, 2021

Mitochon announces funding to support development of MP-201 for TBI

Sep. 29, 2021

Shionogi licenses S-365598 to ViiV for use in ultra long-acting HIV regimens

Sep. 29, 2021

Intranasal subunit SARS-CoV-2 vaccines elicit mucosal and systemic immunity in vivo

Sep. 29, 2021

Targeting KIR3DS1/HLA-F axis as new therapeutic strategy against human adenovirus infections

Sep. 29, 2021

Assessing pharmacologic activity of PD(L)-1 MAb therapeutics in tumors by target pharmacodynamics

Sep. 29, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...